IBM (IBM) PT Maintained at $178 at Stifel on Mixed 3Q Report; 'Services Continued to Improve... Software Degraded More Than Expected'

Go back to IBM (IBM) PT Maintained at $178 at Stifel on Mixed 3Q Report; 'Services Continued to Improve... Software Degraded More Than Expected'

IBM (IBM) Services Unit Reports $240M Multi-Year Agreement with Lenovo to Enhance Remote Call Center Solutions with A.I.

October 18, 2018 9:05 AM EDT

IBM (NYSE: IBM) today announced that it will supply field services and remote call center solutions to enhance the commercial customer experience for Lenovo in its North America, EMEA, and Latin America markets.

The $240M USD multi-year agreement continues to build on the success of the IBM-Lenovo relationship that began in 2005.

Today's customers' expectations for service are changing, and they want to have everything inter-connected, 24x7 with one swipe at a high level of speed and accessibility. In fact, according to IBM's... More

IBM (IBM) PT Lowered to $165 at Wedbush

October 18, 2018 8:12 AM EDT

Wedbush analyst Moshe Katri lowered the price target on IBM (NYSE: IBM) to $165.00 (from $185.00) while maintaining a Neutral rating.

... More

IBM (IBM) PT Lowered to $140 at Cantor Fitzgerald

October 17, 2018 7:45 AM EDT

Cantor Fitzgerald analyst Drew Kootman lowered the price target on IBM (NYSE: IBM) to $140.00 (from $152.00) while maintaining a Neutral rating. IBM had flat constant currency (cc) growth. Strategic Imperatives decelerated in cc in 3Q18 and currency was a headwind after being a tailwind in... More

After-Hours Movers 10/16: (NFLX) (UAL) (LRCX) Higher; (EIGR) (IBM) (UFPI) Lower (more...)

October 16, 2018 5:08 PM EDT

Today's After-Hours Movers

Netflix (NASDAQ: NFLX) 11.2% HIGHER; reported Q3 EPS of $0.89, $0.21 better than the analyst estimate of $0.68. Revenue for the quarter came in at $3.99 billion versus the consensus estimate of $4 billion. Netflixs total net subscriber additions for Q3 were 6.96 million, versus the 5 million forecast from the company. The company sees Q4 net additions of 9.4 million, versus the consensus of 7.7 million.

Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) 8% LOWER; announced positive results from the Phase 2 PREVENT study. PREVENT is a... More

IBM (IBM) Tops Q3 EPS by 2c, Revenue Comes in Light, Offers FY Guidance

October 16, 2018 4:08 PM EDT

IBM (NYSE: IBM) reported Q3 EPS of $3.42, $0.02 better than the analyst estimate of $3.40. Revenue for the quarter came in at $18.8 billion versus the consensus estimate of $19.1 billion.

GUIDANCE:

IBM sees FY2018 EPS of at least $13.80, versus the consensus of... More